Childress Capital Advisors LLC purchased a new position in shares of Mettler-Toledo International Inc. (NYSE:MTD) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 43 shares of the medical instruments supplier’s stock, valued at approximately $49,000.
Other institutional investors have also bought and sold shares of the company. Balasa Dinverno & Foltz LLC bought a new position in shares of Mettler-Toledo International during the 4th quarter worth approximately $264,000. IndexIQ Advisors LLC boosted its holdings in shares of Mettler-Toledo International by 88.1% during the 4th quarter. IndexIQ Advisors LLC now owns 331 shares of the medical instruments supplier’s stock worth $377,000 after buying an additional 155 shares in the last quarter. Barclays PLC lifted its holdings in shares of Mettler-Toledo International by 12.3% in the 4th quarter. Barclays PLC now owns 139,299 shares of the medical instruments supplier’s stock worth $158,757,000 after purchasing an additional 15,288 shares in the last quarter. Concord Wealth Partners bought a new position in shares of Mettler-Toledo International in the 4th quarter worth $105,000. Finally, UBS Asset Management Americas Inc. lifted its holdings in shares of Mettler-Toledo International by 9.8% in the 4th quarter. UBS Asset Management Americas Inc. now owns 134,577 shares of the medical instruments supplier’s stock worth $153,375,000 after purchasing an additional 11,980 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.
In other news, Director Thomas P. Salice sold 1,484 shares of the firm’s stock in a transaction on Monday, February 8th. The stock was sold at an average price of $1,193.00, for a total transaction of $1,770,412.00. Following the completion of the sale, the director now directly owns 45,403 shares of the company’s stock, valued at approximately $54,165,779. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Gerry Keller sold 878 shares of the firm’s stock in a transaction on Tuesday, February 16th. The shares were sold at an average price of $1,192.01, for a total value of $1,046,584.78. Following the sale, the insider now directly owns 623 shares of the company’s stock, valued at $742,622.23. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,700 shares of company stock valued at $18,886,523. Insiders own 3.20% of the company’s stock.
Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, February 4th. The medical instruments supplier reported $9.26 EPS for the quarter, beating analysts’ consensus estimates of $8.72 by $0.54. Mettler-Toledo International had a return on equity of 144.89% and a net margin of 19.36%. The business had revenue of $937.99 million during the quarter, compared to analyst estimates of $903.92 million. During the same period in the prior year, the firm posted $7.78 EPS. As a group, sell-side analysts predict that Mettler-Toledo International Inc. will post 25 EPS for the current fiscal year.
A number of brokerages recently issued reports on MTD. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell increased their target price on Mettler-Toledo International from $1,150.00 to $1,200.00 in a report on Wednesday, December 16th. Wells Fargo & Company increased their target price on Mettler-Toledo International from $1,100.00 to $1,300.00 and gave the stock an “equal weight” rating in a report on Friday, February 5th. Smith Barney Citigroup increased their target price on Mettler-Toledo International from $1,150.00 to $1,200.00 in a report on Wednesday, December 16th. Zacks Investment Research upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $1,255.00 target price on the stock in a report on Tuesday, February 9th. Finally, Cleveland Research upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating in a report on Thursday, December 17th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $968.10.
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.
See Also: What is the Hang Seng index?
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.